Thymidylate synthase (TS) is the enzyme which catalyses
formation of dTMP
(2′-deoxythymidine-5′-monophosphate) from dUMP
(2′-deoxyuridine-5′-monophosphate). The CH3 (methyl) donor is
CH2H4 F (5,10-methylene-tetrahydrofolate).
5-fluorouracil (5FU) is an inhibitor of the TS,
which is a target in chemotherapy of colon cancer.
TS acts in 2 stages:
- dUMP binding to receptor site by which a configurational change
is induced opening an adjacent binding site for CH2H4F. 1 carbon
group of folate transfers to uridine ring, which yields
dihydrofolate and dTMP. dTMP is subsequently phosphorylated by a
kinase to dTDP and dTTP, one of the bases for DNA synthesis.
- The 5FU metabolite, known as FdUMP
(fluorodeoxyuridine monophosphate), is a potential inhibiter of TS.
FdUMP binds at the same site and with the same
affinity as dUMP, but the fluorine atom at the 5′ cannot be
displaced, unlike hydrogen. A ternary complex is
formed subsequently by covalent bonding of TS and reduced folate,
where at 6′ position of FdUMP a cysteine thiol of TS is attached
with 1-C group of folate adjacent to F at the 5′ position.